Prognostic value of inflammation-based markers in limited disease small-cell lung cancer (LD-SCLC)

被引：0
|
作者：
Kaesmann, L. [1 ]
Bolm, L. [1 ]
Janssen, S. [1 ]
Rades, D. [1 ]
机构：
[1] Univ Lubeck, Dept Radiat Oncol, Lubeck, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2017年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V18-3-jD
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [41] Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
    Lee, Jae Min
    Lee, Hong Sik
    Hyun, Jong Jin
    Choi, Hyuk Soon
    Kim, Eun Sun
    Keum, Bora
    Seo, Yeon Seok
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Um, Soon Ho
    Kim, Chang Duck
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 8 (07) : 555 - 562
  • [42] Prognostic value of carbohydrate tumor markers and inflammation-based markers in Chinese advanced gastric cancer patients
    Kong, Weiwei
    Wang, Qing
    Wei, Jia
    Yang, Yang
    Zhang, Yaping
    Zou, Zhengyun
    Liu, Baorui
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC)
    KOMAKI, R
    SHIN, D
    GLISSON, B
    FOSSELLA, F
    MURPHY, W
    GARDEN, A
    OSWALD, M
    HONG, W
    ROTH, J
    PETERS, L
    ELLERBROEK, N
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 188 - 188
  • [44] Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients
    Zhou, Ting
    Zhao, Yuanyang
    Zhao, Shen
    Yang, Yunpeng
    Huang, Yan
    Hou, Xue
    Zhao, Hongyun
    Zhang, Li
    JOURNAL OF CANCER, 2019, 10 (07): : 1685 - 1692
  • [45] A Prognostic Model Integrating Immunohistochemistry Markers for Extensive-Disease Small-Cell Lung Cancer
    Fu, R.
    Zhang, C.
    Zhang, J.
    Yang, J.
    Zhou, Q.
    Yang, X.
    Wu, Y.
    Zhong, W.
    Huang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S794 - S795
  • [46] Evaluating the safety of using G-CSF prophylaxis during concurrent thoracic chemo-radiotherapy (CTRT) in patients with limited-disease small-cell lung cancer (LD-SCLC): Evidence from a phase II trial
    Sheikh, H. Y.
    Colaco, R.
    Ashcroft, L.
    Blackhall, F. H.
    Lorigan, P. C.
    Taylor, P.
    Thatcher, N.
    LUNG CANCER, 2010, 67 : S10 - S11
  • [47] Prognostic value of genomic damage in non small-cell lung cancer
    de Juan, C
    Iniesta, P
    Vega, FJ
    Peinado, MA
    Fernandez, C
    Caldés, T
    Massa, MJ
    López, JA
    Sánchez, A
    Torres, AJ
    Balibrea, JL
    Benito, M
    BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1971 - 1977
  • [48] PHASE I/II STUDY OF INDUCTION CHEMOTHERAPY OF CARBOPLATIN AND IRINOTECAN FOLLOWED BY SEQUENTIAL THORACIC RADIOTHERAPY (TRT) FOR ELDERLY PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG CANCER (LD-SCLC): TORG 0604
    Misumi, Y.
    Okamoto, H.
    Naoki, K.
    Hosomi, Y.
    Takagi, Y.
    Kato, T.
    Masuda, N.
    Takakura, A.
    Minato, K.
    Miura, Y.
    Yokoyama, T.
    Takata, S.
    Kishi, K.
    Nishikawa, M.
    Oshita, F.
    Seki, N.
    Goto, I.
    Watanabe, K.
    ANNALS OF ONCOLOGY, 2014, 25
  • [49] HEXAMETHYLMELAMINE (ALTRETAMINE) IN SMALL-CELL LUNG-CANCER (SCLC)
    COMIS, RL
    CANCER TREATMENT REVIEWS, 1991, 18 : 85 - 90
  • [50] Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer
    Atci, Muhammed Mustafa
    Sakin, Abdullah
    Uysal, Emre
    Aksaray, Ferdi
    Selvi, Oguzhan
    Can, Orcun
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (12): : 1433 - 1437
12345